Dn B Asset Management As Alkermes Plc. Transaction History
Dn B Asset Management As
- $25.3 Billion
- Q3 2025
A detailed history of Dn B Asset Management As transactions in Alkermes Plc. stock. As of the latest transaction made, Dn B Asset Management As holds 13,230 shares of ALKS stock, worth $384,199. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,230
Previous 9,928
33.26%
Holding current value
$384,199
Previous $327,000
21.1%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
400Shares Held
175MCall Options Held
901KPut Options Held
400K-
Black Rock Inc. New York, NY29.1MShares$845 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$528 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$297 Million0.03% of portfolio
-
State Street Corp Boston, MA8.54MShares$248 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY8.09MShares$235 Million1.98% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.77B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...